The U.S. Food and Drug Administration is requesting comments on the potential impact of scheduling changes on the availability for medical use of 16 substances, including certain synthetic cannabinoids and fentanyls (83 Fed. Reg. 50938). The comments will be considered in preparing the U.S. response to a World Health Organization request for information that will be used in determi... Read More